InsidersTradesSigma
Track the 华大基因 share price and the full insider trade history of the company, a listed equity based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 华大基因 has published 4 insider filings. Market capitalisation: €15.3bn. The latest transaction was disclosed on 22 September 2025 (Sale). Among the most active insiders: 汪建. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
华大基因 es una empresa de genómica que ofrece servicios de secuenciación y análisis genético. Cotiza en el mercado XSHE.